Brief

The Human Medicines Regulations 2012 provides lists of approved countries for importing medicines, batch testing, and manufacturing active substances with UK equivalent standards. These lists enable UK importers and wholesalers to continue recognizing QP certification and regulatory standards for active substance manufacture in certain countries. The acceptance of batch testing done in EEA countries will be reviewed before 31 December 2022, with a two-year notice period given in the case of changes.

This content is restricted.

Highlights content goes here...

This content is restricted.

Medicines and Healthcare products Regulatory Agency (MHRA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies